Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Amiloride fails to show benefit in cystic fibrosis trial

Aug. 3, 2000

Researchers determine the structure of antibody-receptor complex key to allergies and asthma

Aug. 2, 2000

Recently issued patent covers B-I's new heterocyclic PDE4 inhibitors

Aug. 1, 2000

Synthesis, activity and use of NK1/NK2 receptor antagonists reported by AstraZeneca

Aug. 1, 2000

AstraZeneca presents novel antiinflammatory compounds for asthma, etc.

July 28, 2000

Maxygen and Karolinska Institute to develop novel allergy therapeutics

July 28, 2000

Fujisawa presents new benzimidazoles active as bradykinin antagonists

July 27, 2000

Interactions between alcohol and rupatadine examined in humans

July 27, 2000

Preparation and use of new lactams as inhibitors of serine proteases, antibiotics

July 26, 2000

Imperial College Innovations launches company for allergy therapies

July 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...